Registries for Rare Diseases
White Paper
Jan 15, 2019
A foundation for multi-arm, multi-company trials
This white paper examines how registries can provide a valuable foundation for multi-arm, multi-company trials by fostering long-term, collaborative relationships between rare disease stakeholders and improving our understanding of diseases and treatment outcomes.
Contact Us
Contact Us

Email Us

Interested in learning more about how IQVIA can create solutions to help you drive healthcare forward?

Call Us

We're available during standard business hours.

U.S. Toll-Free only
+1 866 267 4479

For international call please find a number in our toll-free list.